We’re searching for a Senior Insurance Advisor (remote). Are you searching for new possibilities? Westland Insurance... Group is growing and has an exciting opportunity for a Senior Insurance Advisor reporting to the Timmins, ON branch...
We’re searching for an Insurance Administrator. Are you searching for new possibilities? Westland Insurance Group Ltd... is growing and has a new opportunity for an Insurance Administrator in our Dartmouth branch in Nova Scotia...
leadership team (life insurance). Imagine the freedom of working from home with a flexible schedule that empowers... Coverage: Enjoy peace of mind with our insurance reimbursement program that protects your well-being. 📈 Leadership Training...
or have acquired an Insurance professional designation such as the CIP, FCIP and/or CRM. You hold a minimum of 5 years Claims handling... experience. You possess sound knowledge of regulatory requirements surrounding insurance legislation and compliance...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »